sulofenur has been researched along with Adenocarcinoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aikins, J; Crowell, TA; Grossman, CS; Harper, RW; Howbert, JJ; Kramer, KE; Poore, GA; Rieder, BJ; Rinzel, SM; Tao, EV | 1 |
| Cheshire, PJ; Grindey, GB; Houghton, JA; Houghton, PJ; Lutz, L; Myers, L; Toth, J | 1 |
| Berezesky, IK; Boder, GB; Jain, PT; Phelps, PC; Trump, BF | 1 |
| Boder, GB; Grindey, GB; Houghton, PJ; Sosinski, J; Thakar, JH | 1 |
| Germain, GS; Harwood, FC; Houghton, PJ; Sosinski, J; Thakar, JH | 1 |
| Houghton, JA; Houghton, PJ | 1 |
| Coleman, R; Hatty, S; Kamthan, A; Peters, B; Scarffe, JH; Smyth, JF; Walling, J | 1 |
| Alberts, DS; Fossella, FV; Hardy, J; Haynes, TR; Lippman, SM; O'Brien, M; Seitz, DE; Taylor, CW; Wiltshaw, E; Wolen, RL | 1 |
| Bailey, FC; Germain, GS; Grindey, GB; Houghton, JA; Houghton, PJ; Witt, BC | 1 |
1 review(s) available for sulofenur and Adenocarcinoma
| Article | Year |
|---|---|
Antitumor diarylsulfonylureas: novel agents with unfulfilled promise.
Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Agents; Benzofurans; Child; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Drug Resistance, Multiple; Humans; Phenylurea Compounds; Sulfonylurea Compounds; Transplantation, Heterologous | 1996 |
2 trial(s) available for sulofenur and Adenocarcinoma
| Article | Year |
|---|---|
A phase II study of sulofenur (LY186641) in gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Sulfonylurea Compounds | 1992 |
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Interactions; Female; Humans; Hypoprothrombinemias; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Sulfonylurea Compounds; Warfarin | 1991 |
6 other study(ies) available for sulofenur and Adenocarcinoma
| Article | Year |
|---|---|
Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Humans; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Multiple Myeloma; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Sulfonylurea Compounds; Tumor Cells, Cultured | 1990 |
Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl)sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Benzofurans; Colonic Neoplasms; Female; Humans; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Phenylurea Compounds; Sulfonylurea Compounds; Transplantation, Heterologous | 1995 |
Sulofenur cytotoxicity and changes in cytosolic calcium and mitochondrial membrane potential in human colon adenocarcinoma cell lines.
Topics: Adenocarcinoma; Calcium; Cell Death; Cell Survival; Colonic Neoplasms; Cytosol; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Membrane Potentials; Microscopy, Electron; Mitochondria; Sulfonylurea Compounds; Tumor Cells, Cultured | 1995 |
Characterization of the intracellular distribution and binding in human adenocarcinoma cells of N-(4-azidophenylsulfonyl)-N'-(4-chlorophenyl)urea (LY219703), a photoaffinity analogue of the antitumor diarylsulfonylurea sulofenur.
Topics: Adenocarcinoma; Affinity Labels; Antineoplastic Agents; Cell-Free System; Drug Resistance; Humans; Mitochondria; Photochemistry; Subcellular Fractions; Sulfonylurea Compounds; Tumor Cells, Cultured | 1995 |
Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug action.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Death; Cell Division; DNA Damage; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Neoplasms, Experimental; Nucleosomes; Sulfonylurea Compounds; Tumor Cells, Cultured | 1993 |
N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Blood Physiological Phenomena; Cell Division; Cell Survival; Colonic Neoplasms; Culture Media; Humans; Serum Albumin; Sulfonylurea Compounds; Tumor Cells, Cultured | 1990 |